Published online April 1, 2008
PEDIATRICS Vol. 121 No. 4 April 2008, pp. e810-e816 (doi:10.1542/peds.2007-1519)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malik, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malik, S.
Related Collections
Right arrow Heart & Blood Vessels
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Maternal Smoking and Congenital Heart Defects

Sadia Malik, MD, MPHa, Mario A. Cleves, PhDa, Margaret A. Honein, PhD, MPHb, Paul A. Romitti, PhDc, Lorenzo D. Botto, MDd, Shengping Yang, MSa, Charlotte A. Hobbs, MD, PhDa and the National Birth Defects Prevention Study

a Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
b National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
c Department of Epidemiology, University of Iowa, Iowa City, Iowa
d Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah

OBJECTIVES. In a population-based case-control study, we investigated the association between congenital heart defects and maternal smoking.

METHODS. The National Birth Defects Prevention Study enrolled 3067 infants with nonsyndromic congenital heart defects and their parents and 3947 infants without birth defects and their parents. Affected infants had ≥1 of the following defects: conotruncal, septal, anomalous pulmonary venous return, atrioventricular septal defects, and left-sided or right-sided obstructive heart defects. Mothers of case and control infants were asked if they smoked during the periconceptional period, defined as 1 month before pregnancy through the first trimester. Maternal home and workplace exposure to tobacco smoke during the same period was also determined. Logistic regression was used to compute odds ratios and 95% confidence intervals while controlling for potential confounders.

RESULTS. Case infants were more likely to be premature and have lower birth weight than control infants. Women who smoked anytime during the month before pregnancy to the end of the first trimester were more likely to have infants with septal heart defects than women who did not smoke during this time period. This association was stronger for mothers who reported heavier smoking during this period. This relation was independent of potential confounding factors, including prenatal vitamin use, alcohol intake, maternal age, and race or ethnicity. Women who smoked ≥25 cigarettes per day were more likely than nonsmoking mothers to have infants with right-sided obstructive defects. There was no increased risk of congenital heart defects with maternal exposure to environmental tobacco smoke.

CONCLUSIONS. Maternal smoking during pregnancy was associated with septal and right-sided obstructive defects. Additional investigation into the timing of tobacco exposure and genetic susceptibilities that could modify this risk will provide a more precise evidence base on which to build clinical and public health primary prevention strategies.

Key Words: smoking • pregnancy • congenital heart defects

Abbreviations: CHD—congenital heart defect • ETS—environmental tobacco smoke • ASD—atrial septal defect • NBDPS—National Birth Defects Prevention Study • VSD—ventricular septal defect • OR—odds ratio • CI—confidence interval • NOS—nitric oxide synthase

Accepted Aug 27, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
M. E. Cogswell, R. H. Bitsko, M. Anderka, A. R. Caton, M. L. Feldkamp, S. M. H. Sherlock, R. E. Meyer, T. Ramadhani, J. M. Robbins, G. M. Shaw, et al.
Control Selection and Participation in an Ongoing, Population-based, Case-Control Study of Birth Defects: The National Birth Defects Prevention Study
Am. J. Epidemiol., October 15, 2009; 170(8): 975 - 985.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. T.C. Shieh and D. Srivastava
Heart Malformation: What Are the Chances It Could Happen Again?
Circulation, July 28, 2009; 120(4): 269 - 271.
[Full Text] [PDF]

Home page
 CirculationHome page
WRITING GROUP MEMBERS, D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, et al.
Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation, January 27, 2009; 119(3): e21 - e181.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. R. Gray, R. Magri, D. M. Shakleya, and M. A. Huestis
Meconium Nicotine and Metabolites by Liquid Chromatography-Tandem Mass Spectrometry: Differentiation of Passive and Nonexposure and Correlation with Neonatal Outcome Measures
Clin. Chem., December 1, 2008; 54(12): 2018 - 2027.
[Abstract] [Full Text] [PDF]